• 1
    Walsh S, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993; 169: 14561461.
  • 2
    Hubel C, Roberts J, Taylor R, Musci T, Rogers G, McLaughlin M. Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J obstet Gynecol 1989; 161: 10251034.
  • 3
    Maseki M, Nishigaki I, Hagihara M, Tomoda Y, Yagi K. Lipid peroxide levels and lipid content of serum lipoprotein fractions of pregnant subjects with or without pre-eclampsia. Clinica Chimica Acta 1981; 115: 155161.
  • 4
    Branch D, Mitchell M, Miller E, Palinski W, Witztum J. Preeclampsia and serum antibodies to oxidised low-density lipoprotein. Lancet 1994; 343 645646.
  • 5
    Janero D. Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative injury. Free Rad Biol Med 1990; 9515540.
  • 6
    Palinski W, Horkko S, Miller E et al. Cloning of monoclonal anti bodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma. J Clin Invest 1996; 98: 800814.
  • 7
    Uusitupa M, Niskanen L, Luoma J et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vase Biol 1996; 16:12361242.
  • 8
    Pihkala J, Hakala T, Voutilainen P, Raivio K. Uudet suomalaiset sikiön kasvukäyrät. Duodecim 1989; 105: 15401546 (in Finnish).
  • 9
    Jaakkola O, Solakivi T, Ylä-Herttuala S, Nikkari T. Receptor-mediated binding and degradation of subfractions of human plasma low-density lipoprotein by cultured fibroblasts. Biochem Biophys Acta 1989; 1005 118122.
  • 10
    Haberland M, Fogelman A, Edwards P. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc Natl Acad Sci USA 1982; 79 17121716.
  • 11
    Bellomo G, Maggi E, Poli M, Agosta F, Bollati P, Finardi G. Autoantibodies against oxidatively modified low-density lipoproteins in NIDDM. Diabetes 1995; 44: 6066.
  • 12
    Halliwell B. Oxidation of low-density lipoproteins: questions of initiation, propagation, and the effect of antioxidants. Am J Clin Nutr 1995; 61 (Suppl): 670S677S.
  • 13
    Armstrong V, Wieland E, Diedrich F et al. Serum antibodies to oxidised low-density lipoprotein in pre-eclampsia and coronary heart disease. Lancet 1994; 343: 1570.
  • 14
    Raitakdri O, Pitkänen O-P, Lehtimäki T et al. In vivo low density lipoprotein oxidation relates to coronary reactivity in young men. J Am CON Cardiol 1997; 30 97102.
  • 15
    Zeeman G, Dekker G, Geijn H, Kraayenbrink A. Endothelial function in normal and pre-eclamptic pregnancy: a hypothesis. Eur J Obstet Gynecol 1992; 43: 113122.
  • 16
    Kurki T, Ailus K, Palosuo T et al. Antibodies to oxidized low-density lipoprotein, cardiolipin, and phosphatidyl serine fail to predict the risk of preeclampsia. Hypertens Pregn 1996; 15: 251256.